Renaissance Technologies’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39
| Closed | -$23K | – | 3962 |
|
|
2024
Q1 | $23K | Sell |
39
-36
| -48% | -$38.8K | ﹤0.01% | 3579 |
|
|
2023
Q4 | $97K | Buy |
75
+5
| +7% | +$8.05K | ﹤0.01% | 3310 |
|
|
2023
Q3 | $122K | Buy |
70
+4
| +6% | +$14.6K | ﹤0.01% | 3204 |
|
|
2023
Q2 | $334K | Buy |
66
+5
| +8% | +$37.9K | ﹤0.01% | 3083 |
|
|
2023
Q1 | $723K | Buy |
61
+1
| +2% | +$17.2K | ﹤0.01% | 2675 |
|
|
2022
Q4 | $471K | Sell |
60
-34
| -36% | -$293K | ﹤0.01% | 2984 |
|
|
2022
Q3 | $1M | Buy |
94
+62
| +194% | +$1.52M | ﹤0.01% | 2497 |
|
|
2022
Q2 | $1.02M | Buy |
32
+2
| +7% | +$148K | ﹤0.01% | 2704 |
|
|
2022
Q1 | $4.42M | Buy |
30
+13
| +76% | +$1.99M | 0.01% | 1685 |
|
|
2021
Q4 | $3.83M | Buy |
17
+8
| +89% | +$2.54M | ﹤0.01% | 1689 |
|
|
2021
Q3 | $3.63M | Sell |
9
-2
| -18% | -$974K | ﹤0.01% | 1660 |
|
|
2021
Q2 | $8M | Sell |
11
-2
| -15% | -$1.47M | 0.01% | 1328 |
|
|
2021
Q1 | $10.8M | Buy |
+13
| New | +$9.94M | 0.01% | 1143 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3157 |
|
|
2020
Q2 | – | Hold |
0
| – | -$217K | – | 3774 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$663K | – | 3084 |
|
|
2019
Q4 | $375K | Buy |
+1
| New | +$1.59M | ﹤0.01% | 2999 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3236 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3310 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3149 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3218 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3198 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2689 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3050 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3066 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3020 |
|
|
2017
Q2 | – | Hold |
0
| – | -$225K | – | 3362 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2976 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2861 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 2998 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3098 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1.15M | – | 3368 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2384 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2498 |
|
Other funds holding TNXP
RA
HF
TRCT
Renaissance Technologies's TNXP Position: Q2 2024 in Review
Renaissance Technologies sold out of Tonix Pharmaceuticals (TNXP) in Q2 2024, closing a stake of 39 shares — an estimated $23K sold.
Renaissance Technologies first reported a position in TNXP in Q4 2019 and held it in 14 quarters. The position peaked at $10.8M in Q1 2021. 13 funds tracked by Wall St. Rank hold TNXP as of Q2 2024.
- Renaissance Technologies reported no remaining Tonix Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Renaissance Technologies sold 39 Tonix Pharmaceuticals shares in Q2 2024, an estimated $23K.
- Renaissance Technologies first reported a position in Tonix Pharmaceuticals in Q4 2019 and held it in 14 quarters.
- Renaissance Technologies's Tonix Pharmaceuticals position peaked at $10.8M in Q1 2021.
- 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2024.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.